甲狀腺癌BRAF突變到跨足各類癌症的標靶治療Thyroid Cancer BRAF Mutation: Targeted Therapy Effectiveness Across All Cancer

甲狀腺癌中的BRAF突變及發展成一種不分癌種限制的適應症，標靶藥物在此突變型患者中表現出色。這一發現為多類癌症患者帶來新希望，開啟了一條有效治療之路。

BRAF mutation in thyroid cancer proves responsive to targeted therapy, irrespective of cancer type. This breakthrough offers new hope to diverse cancer patients, paving the way for effective treatments.

🙋‍♂️請追蹤腫瘤科醫師的生活點滴🙋‍♂️
💝臉書facebook：
https://m.facebook.com/profile.php/?id=100063644122566
💝Instagram：
https://instagram.com/chiaoenpeter?igshid=OGQ5ZDc2ODk2ZA==
💝加入頻道會員：
https://www.youtube.com/channel/UCBvUlnJq3TpnGtbV6fdnl2A/join
💝分享會員專屬影片：
https://www.youtube.com/playlist?list=UUMOBvUlnJq3TpnGtbV6fdnl2A